Modulari-T

Modulari-T is a biotechnology company focused on advancing cell therapy through innovative approaches to T cell receptor functionality. The company operates on the premise that the immune system has inherent blueprints that can be utilized to enhance therapeutic outcomes. Their core technology comprises two components: the Modular Actuation Receptor Complex (MARC) and the Modular Vector (MoVe). This dual technology system aims to address the limitations currently faced by first-generation cell therapies, particularly in oncology.

The Modulari-T platform is designed to improve the efficacy and…